| MEGRX | VIGRX | MEGRX / VIGRX | |
| Total Expense Ratio | 1.08 | 0.17 | 635% |
| Annual Report Gross Expense Ratio | 1.09 | 0.17 | 641% |
| Fund Existence | 22 years | 33 years | - |
| Gain YTD | -5.017 | 20.611 | -24% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 44.4B | 353B | 13% |
| Annual Yield % from dividends | 0.00 | 0.30 | - |
| Returns for 1 year | -8.11 | 16.34 | -50% |
| Returns for 3 years | 39.51 | 134.39 | 29% |
| Returns for 5 years | 12.90 | 97.14 | 13% |
| Returns for 10 years | 130.27 | 359.04 | 36% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPNS | 27.27 | 0.02 | +0.08% |
| Calamos Nasdaq-100 Str Alt Prt ETF-Sep | |||
| CDEI | 83.16 | N/A | N/A |
| Calvert US Large-Cp Div, Eq AndIncETF | |||
| FELC | 38.64 | N/A | N/A |
| Fidelity Enhanced Large Cap Core ETF | |||
| PSFF | 32.31 | -0.03 | -0.09% |
| Pacer Swan SOS Fund of Funds ETF | |||
| SBIO | 52.20 | -0.70 | -1.32% |
| ALPS Medical Breakthroughs ETF | |||